← Back to patent-cliff list
Hylastan
Tier C — Watch / tradeHylastan
Genzyme Corporation
Originator
2009
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Hyaluronic acid
Brand：Jonexa
Indications (approved)：Knee arthritis
Regional status
US
No progress
2004-10-01
EU
Approved
2009-09-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Hylastan?
Approved indications include: Knee arthritis.
When does the Hylastan patent expire?
No public expiry year is available for Hylastan yet; this page updates once verified.
How do I get a quote for Hylastan intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29